1. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
2. How many members does the Policy Board consist of?
3. Which type of research involves intervention, treatment, or medication programs using human subjects?
4. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
5. What condition must be met for an application for renewal of a licence to be entertained?
6. What is the Appellate Board's authority to call for the record of a case for review?
7. For drugs other than those falling under specific categories, whose approval is required for the specifications?
8. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
9. What type of containers are ophthalmic solutions and suspensions required to be contained in?
10. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
11. What is the purpose of Form 6?
12. What is the duration of a license to export drugs?
13. What is the term of office for members of the Registration Board?
14. When can deviations be made from the information submitted during the registration of a drug?
15. What is the purpose of an "airlock" in pharmaceutical manufacturing?
16. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
17. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
18. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
19. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
20. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
21. What is the age requirement for the Chief Executive Officer (CEO) of the Authority?
22. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
23. The Drugs Act, 1976 extends to which of the following areas?
24. Who qualifies as a Federal Inspector according to these rules?
25. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
26. What is the tenure of the CEO's appointment, and how many times can it be extended?
27. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
28. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
29. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
30. Who serves as the ex-officio Chairman of the Appellate Board?
31. Which of the following statements about advertisement material is NOT true?
32. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
33. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
34. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
35. Within what time frame should the Authority submit its annual report to the Federal Government?
36. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
37. What substances are NOT included in the definition of "Drug" under Schedule-I?
38. Which power of the Inspector requires specific authorization by the Government?
39. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
40. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
41. What does the term "Advertise" mean under Schedule-II?
42. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
43. What does an Inspector require from a person during a search or seizure under Schedule-V?
44. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
45. What is the purpose of the license to manufacture drugs for experimental purposes?
46. What kind of offense is non-cognizable under the Drugs Act 1976?
47. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
48. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
49. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
50. Which power of the Inspector requires specific authorization by the Government?
51. In which situations may the Registration Board provisionally register a drug for a period of two years?
52. What is the purpose of the criteria regarding medical representatives?
53. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
54. What is the role of the Quality Control Department in the manufacturing process?
55. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
56. Who shall not be liable for a contravention of Section 23 of the Drugs Act 1976?
57. Which of the following offenses punishable under Schedule-III is non-cognizable?
58. What are "Medical Devices" under Schedule-I?
59. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
60. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
61. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
62. Who is responsible for carrying out the audit of the Authority's accounts?
63. What is the penalty for a person who fails to provide information requested by the Authority?
64. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
65. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
66. Who is responsible for maintaining records of quarterly production and disposal of a drug?
67. What substances are NOT included in the definition of "Drug" under Schedule-I?
68. What is the meaning of "sponsor" in the context of the Drugs (Research) Rules?
69. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
70. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
71. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
72. Which of the following is NOT considered as "Therapeutic goods" under the Act?
73. What is the short title of the rules that govern the Drugs Appellate Board?
74. What does the term "batch number (or lot number)" refer to?
75. Under what conditions is contract manufacture permissible?
76. What is the maximum duration for which the approval of an advertisement under sub-rule (1) is valid?
77. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
78. What is the fee for the renewal of registration of a new drug?
79. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
80. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
81. Under what condition can finished drugs be imported?
82. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
83. What is the main duty of a Federal Inspector?
84. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
85. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
86. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
87. What labeling requirements apply to drugs manufactured for experimental purposes?
88. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
89. What is the role of the Quality Control Department in the manufacturing process?
90. Which of the following offenses punishable under Schedule-III is non-cognizable?
91. Within what time frame should the Authority submit its annual report to the Federal Government?
92. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
93. What action should the Authority take in response to objections raised by the Auditor-General?
94. What is the commencement date for the Drugs (Specifications) Rules, 1978?
95. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
96. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
97. What does the term "Advertise" mean under Schedule-II?
98. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
99. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
100. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
